
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY24
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Natural Capsules Ltd (NATCAPSUQ) is currently trading at 170.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Natural Capsules Limited is a leading manufacturer of hard gelatin and cellulose capsule shells, pioneering vegetarian capsules in India. The company is navigating challenges, notably US tariffs on HPMC capsules, impacting market growth. Despite these, it remains focused on expanding HPMC production capacity. Strategic actions include collaborating with Chinese consultants for scaling up API production amid facing technical hurdles. The company anticipates significant improvements post these interventions, potentially enhancing market reach and profitability over time.
Over the past 52 weeks, Natural Capsules Ltd has traded between a low of ₹163.00 and a high of ₹299.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Natural Capsules Ltd has a market capitalization of approximately 175.18. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Natural Capsules Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
You can buy shares of Natural Capsules Ltd (NATCAPSUQ) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.
Based on its market capitalization of 175.18 Cr, Natural Capsules Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Natural Capsules Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Natural Capsules Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Natural Capsules Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.
Key risks associated with Natural Capsules Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.
Bearish
3
Neutral
4
Bullish
7
Bearish
34
Neutral
4
Bullish
8
Bearish
31
Neutral
0
Bullish
1

Market Cap
₹ 175 Cr
P/E
—
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
175 Cr
Low Risk
—
29.9
—
0.8
299.00
163.00
Sales CAGR
1Y
8.87%
3Y
7.53%
5Y
22.23%
10Y
11.70%
Profit CAGR
1Y
-88.83%
3Y
-21.65%
5Y
50.91%
10Y
4.97%
ROE
TTM
-4.87%
3Y
7.98%
5Y
9.63%
10Y
7.53%
ROCE
TTM
-1.11%
3Y
11.86%
5Y
13.59%
10Y
10.99%
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
LOW MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 2.24 L in last 5 Years